| CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer H Ling, R Spizzo, Y Atlasi, M Nicoloso, M Shimizu, RS Redis, N Nishida, ... Genome research 23 (9), 1446-1461, 2013 | 679 | 2013 |
| The interplay of epigenetic marks during stem cell differentiation and development Y Atlasi, HG Stunnenberg Nature Reviews Genetics 18 (11), 643-658, 2017 | 481 | 2017 |
| OCT‐4, an embryonic stem cell marker, is highly expressed in bladder cancer Y Atlasi, SJ Mowla, SAM Ziaee, AR Bahrami International journal of cancer 120 (7), 1598-1602, 2007 | 414 | 2007 |
| OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells Y Atlasi, SJ Mowla, SAM Ziaee, PJ Gokhale, PW Andrews Stem cells 26 (12), 3068-3074, 2008 | 380 | 2008 |
| Dynamic reorganization of extremely long-range promoter-promoter interactions between two states of pluripotency O Joshi, SY Wang, T Kuznetsova, Y Atlasi, T Peng, PJ Fabre, E Habibi, ... Cell stem cell 17 (6), 748-757, 2015 | 199 | 2015 |
| Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2 RS Redis, LE Vela, W Lu, JF de Oliveira, C Ivan, C Rodriguez-Aguayo, ... Molecular cell 61 (4), 520-534, 2016 | 177 | 2016 |
| OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor MH Asadi, SJ Mowla, F Fathi, A Aleyasin, J Asadzadeh, Y Atlasi International journal of cancer 128 (11), 2645-2652, 2011 | 120 | 2011 |
| Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation Y Atlasi, R Noori, C Gaspar, P Franken, A Sacchetti, H Rafati, T Mahmoudi, ... PLoS genetics 9 (5), e1003424, 2013 | 87 | 2013 |
| Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2 S Tahmasebi, SM Jafarnejad, IS Tam, T Gonatopoulos-Pournatzis, ... Proceedings of the National Academy of Sciences 113 (44), 12360-12367, 2016 | 78 | 2016 |
| Queuine links translational control in eukaryotes to a micronutrient from bacteria M Müller, C Legrand, F Tuorto, VP Kelly, Y Atlasi, F Lyko, ... Nucleic acids research 47 (7), 3711-3727, 2019 | 62 | 2019 |
| Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer Y Atlasi, SJ Mowla, SAM Ziaee Cancer detection and prevention 32 (4), 308-313, 2009 | 59 | 2009 |
| Epigenetic modulation of a hardwired 3D chromatin landscape in two naive states of pluripotency Y Atlasi, W Megchelenbrink, T Peng, E Habibi, O Joshi, SY Wang, ... Nature cell biology 21 (5), 568-578, 2019 | 57 | 2019 |
| Cancer stem cells, pluripotency, and cellular heterogeneity: a WNTer perspective Y Atlasi, L Looijenga, R Fodde Current topics in developmental biology 107, 373-404, 2014 | 51 | 2014 |
| STARR-seq identifies active, chromatin-masked, and dormant enhancers in pluripotent mouse embryonic stem cells T Peng, Y Zhai, Y Atlasi, M Ter Huurne, H Marks, HG Stunnenberg, ... Genome biology 21, 1-27, 2020 | 50 | 2020 |
| Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation L Erdem-Eraslan, Y Gao, NK Kloosterhof, Y Atlasi, J Demmers, ... European Journal of Cancer 51 (7), 893-903, 2015 | 30 | 2015 |
| Dynamic CpG methylation delineates subregions within super-enhancers selectively decommissioned at the exit from naive pluripotency E Bell, EW Curry, W Megchelenbrink, L Jouneau, V Brochard, RA Tomaz, ... Nature communications 11 (1), 1112, 2020 | 29 | 2020 |
| Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report AM Shafaroudi, SJ Mowla, SAM Ziaee, AR Bahrami, Y Atlasi, ... Urology journal 5 (2), 99-105, 2008 | 27 | 2008 |
| Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors M Malakootian, SJ Mowla, H Saberi, MH Asadi, Y Atlasi, AM Shafaroudi Molecular Carcinogenesis 49 (9), 818-825, 2010 | 23 | 2010 |
| The translational landscape of ground state pluripotency Y Atlasi, SM Jafarnejad, CG Gkogkas, M Vermeulen, N Sonenberg, ... Nature communications 11 (1), 1617, 2020 | 22 | 2020 |
| The role of S100a4 (Mts1) in Apc-and Smad4-driven tumour onset and progression Y Atlasi, R Noori, I Marolin, P Franken, J Brandao, K Biermann, P Collini, ... European journal of cancer 68, 114-124, 2016 | 14 | 2016 |
